STRAP — Strategic Partners A/S Share Price
- DKK45.05m
- DKK41.16m
- 10
- 21
- 71
- 22
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.34 | ||
Price to Tang. Book | 2.34 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -1.04% | ||
Return on Equity | -1.78% | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | DKKm | n/a | n/a | n/a | n/a | n/a | 5,958 | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Strategic Partners A/S, formerly Orphazyme A/S, is a Denmark-based company active within the biopharmaceutical industry. It develops new therapies for the treatment of a family of genetic disorders. The Company's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases. The Company’s candidate, arimoclomol, stimulates the production of the cells’ protein rescue system, the heat shock proteins, which helps the misfolded proteins to either get back to their functional shape or, if this cannot be achieved, remove them from the cells by means of the cells’ recycling system, the lysosomes, so they no longer form toxic aggregates. The Company collaborates with academic institutions in Europe and the United States.
Directors
- Georges Gemayel CHM (61)
- Christophe Bourdon CEO
- Bo Hansen VCH (63)
- Anders Fink Vadsholt CFO (47)
- Thomas Kirkegaard Jensen CSO
- Thomas Blaettler OTH
- Martin Bonde DRC
- Stephanie Okey DRC
- Sten Verland DRC
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 19th, 2009
- Public Since
- November 17th, 2017
- No. of Employees
- 1
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange - Copenhagen
- Shares in Issue
- 41,712

- Address
- Lyskaer 8A, KOEBENHAVN, 2730
- Web
- https://www.strategic-partners.dk/kontakt-os/
- Phone
- Auditors
- KPMG
Upcoming Events for STRAP
Q2 2025 Strategic Partners A/S Earnings Release
Similar to STRAP
Genmab A/S
OMX Nordic Exchange - Copenhagen
Gubra A/S
OMX Nordic Exchange - Copenhagen
ViroGates A/S
OMX Nordic Exchange - Copenhagen
Zealand Pharma A/S
OMX Nordic Exchange - Copenhagen
FAQ
As of Today at 23:27 UTC, shares in Strategic Partners A/S are trading at DKK1,080.00. This share price information is delayed by 15 minutes.
Shares in Strategic Partners A/S last closed at DKK1,080.00 and the price had moved by -1.82% over the past 365 days. In terms of relative price strength the Strategic Partners A/S share price has underperformed the FTSE Global All Cap Index by -4.28% over the past year.
The overall consensus recommendation for Strategic Partners A/S is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreStrategic Partners A/S does not currently pay a dividend.
Strategic Partners A/S does not currently pay a dividend.
Strategic Partners A/S does not currently pay a dividend.
To buy shares in Strategic Partners A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of DKK1,080.00, shares in Strategic Partners A/S had a market capitalisation of DKK45.05m.
Here are the trading details for Strategic Partners A/S:
- Country of listing: Denmark
- Exchange: CPH
- Ticker Symbol: STRAP
Based on an overall assessment of its quality, value and momentum Strategic Partners A/S is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Strategic Partners A/S is DKK108.00. That is 90% below the last closing price of DKK1,080.00.
Analysts covering Strategic Partners A/S currently have a consensus Earnings Per Share (EPS) forecast of DKK81.35 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Strategic Partners A/S. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -0.07%.
As of the last closing price of DKK1,080.00, shares in Strategic Partners A/S were trading +17.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Strategic Partners A/S PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at DKK1,080.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Strategic Partners A/S' management team is headed by:
- Georges Gemayel - CHM
- Christophe Bourdon - CEO
- Bo Hansen - VCH
- Anders Fink Vadsholt - CFO
- Thomas Kirkegaard Jensen - CSO
- Thomas Blaettler - OTH
- Martin Bonde - DRC
- Stephanie Okey - DRC
- Sten Verland - DRC